The Role of Physician Professional Networks in Physicians’ Receipt of Pharmaceutical and Medical Device Industries’ Payments
Author:
Funder
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11606-021-06802-9.pdf
Reference34 articles.
1. Lo B, Field MJ (eds) Conflict of Interest in Medical Research, Education, and Practice. Washington (DC); 2009.
2. Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006;355(22):2330-2337.
3. Rose SL, Sah S, Dweik R, Schmidt C, Mercer M, Mitchum A, et al. Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment. Organ Behav Hum Decis Process. 2019.
4. Lerner TG, Miranda Mda C, Lera AT, Ueda A, Briones B, Del Giglio A, et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemp Clin Trials. 2012;33(5):1019-1022.
5. Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2015;33(1):100-106.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quantifying Industry Spending on Promotional Events Using Open Payments Data;JAMA Health Forum;2024-06-28
2. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study;Journal of General Internal Medicine;2023-11-14
3. Characterizing industry payments to US teaching hospitals and affiliated physicians: a cross-sectional analysis of the Open Payments datasets from 2016 to 2022;Health Affairs Scholar;2023-07-31
4. The Role of Physician Networks and Receipt of Opioid-Related Payments;Journal of General Internal Medicine;2022-11-14
5. Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act;Big Data & Society;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3